Intellia Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$12.31

+0.45 (+3.79%)

As of Nov 7, 1:49 AM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 14 58%

Hold 7 29%

Sell 3 13%

Price Target

Analyst Price Target +164.1% upside

Low Target $20.88

Average Target $32.51

High Target $45.64

Current Price $12.31

Current
$12.31

Target
$32.51

$20.88 $32.51 avg $45.64

Scenario Analysis

Bear Case

$20.88

69.6%

Low target

Base Case

$32.51

+164.1%

Avg target

Bull Case

$45.64

+270.8%

High target

Risk/Reward

3.9x

Highly favorable

Price in Context

52-Week High

$18.48

-33.4% from high

52-Week Low

$7.95

+54.8% from low

Target vs 52W High

$32.51

+75.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%